Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Immunology: What Is It Good For?

Bharat Kumar, MD, MME, FACP, FAAAAI, RhMSUS  |  Issue: November 2023  |  November 8, 2023

Immunology so pervades the conversations of rheumatologists that even our mindsets are determined by these antibodies and white blood cells. Our inner assumptions when we hear the word spondyloarthritis are totally different than we hear the word dsDNA. But without having reinforcement of immunological concepts, these assumptions can lead to considerable miscommunication. That’s why it’s necessary for all of us to keep reinforcing our immunological knowledge; these concepts change over time.

Speaking of change, it’s vital for practicing rheumatologists to understand the basics of clinical immunology because it forms that vital connection with basic science, clinical science and translational research. Because grant writing and publication take so much time that research is now a full-time job, there is a growing chasm between clinicians and researchers. Understanding immunology can help us narrow that chasm for the interests of our patients and advancing the field.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Anti-Boredom Antibodies

Even with these elaborated reasons, there’s a deeper justification for periodically revisiting our knowledge base regarding immunology. Immunology is fun. Immunology is full of stories that we create regarding how the world works. By listening to these stories and contributing to them, we have fun and expand the magic and joy of the world around us.

So much of what drives our burnout in clinical settings is the mundane aspect of disease. As a fellowship program director, I’ve heard trainees over the years becoming more and more bored by “another case of gout.” Certainly, we can continue our career development by just dispensing allopurinol and colchicine for gout and making our income accordingly. But without a deeper exploration into why each case of gout is unique and is a mystery worth exploring, it becomes a chore to treat the condition rather than an adventure.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Immunology is also something that is intellectually stimulating. There’s an intangible joy that comes out of uncovering those connections between what appear to be disparate elements of the immune system. A patient of mine with chronic spontaneous urticaria developed ankylosing spondylitis. It seemed to be two separate conditions, but looking into the immunology, it appears there’s a role for mast cells in spondyloarthritis.3 Although that knowledge didn’t change the medication therapy plan, it provided me a lot of joy to connect these two dots and to relay it to a patient desperately looking for answers.

Diversity, Equity … & Immunology

The last reason it is vital for practicing rheumatologists to embrace immunology is because it has major ramifications on diversity, equity and inclusion. After all, even a cursory glance into the history of immunology shows a massive blind spot when examining the immune systems of patients from marginalized and minoritized communities.4 The clinical immunology community has been racing to identify the biases inherent within the historical dogmas of the field—and, as practicing rheumatologists, we need to be aware of these as well.

Page: 1 2 3 4 | Single Page
Share: 

Filed under:OpinionRheuminations Tagged with:Immunology

Related Articles

    Exploring the Complement System in Human Disease

    February 1, 2010

    Novel disease associations revealed by whole genome screens

    A 52-Year-Old Lupus Paper Remains Important Today

    December 14, 2020

    Over 50 years ago, an article appeared in The New England Journal of Medicine: “Immunologic Factors and Clinical Activity in Systemic Lupus Erythema­tosus.”1 Written by a young postdoctoral fellow, Peter H. Schur, MD, and colleagues, the article synthesized important work in the field at the time. What follows is a discussion of the historical context…

    Researchers Seek ANCA-Associated Vasculitis Subtype Markers

    October 19, 2020

    New research on complement activation in anti-neutrophil cytoplasmic antibody (ANCA) associated vasculitis underscores its important role in the patho­genesis of this disease, an autoimmune condition defined by inflammation of small- and medium-caliber blood vessels.1 ANCA testing is commonly performed to help diagnose granulomatosis with polyangiitis and microscopic polyangiitis, both of which are forms of ANCA-associated…

    2015 ACR/ARHP Annual Meeting: Cellular Triggers in Inflammatory Disease

    April 14, 2016

    SAN FRANCISCO—What factors help determine whether or not inflammation resolves, leading to healing, or becomes chronic, leading to disease and tissue destruction? A number of important cells, including toll-like receptors, mast cells, anti-citrullinated protein antibodies, complement and interferon, all play their own role in this process. By understanding how they act in innate and adaptive…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences